97459-72-8

Basic information

• Product Name: 4-(2-methoxy-4-nitrophenyl)morpholine
• Synonyms: 4-(2-methoxy-4-nitrophenyl)morpholine;morpholine, 4-(2-methoxy-4-nitrophenyl)-
• CAS NO: 97459-72-8
• Molecular Formula: C₁₁H₁₄N₂O₄
• Molecular Weight: 238.25
• Mol File: 97459-72-8.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 425.601°C at 760 mmHg
• Flash Point: 211.196°C
• Appearance: /
• Density: 1.263g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.563
• Storage Temp.: 2-8°C
• PKA: 1.66±0.40(Predicted)
• CAS DataBase Reference: 4-(2-methoxy-4-nitrophenyl)morpholine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-methoxy-4-nitrophenyl)morpholine(97459-72-8)
• EPA Substance Registry System: 4-(2-methoxy-4-nitrophenyl)morpholine(97459-72-8)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 97459-72-8(Hazardous Substances Data)

Usage

General Description

4-(2-methoxy-4-nitrophenyl)morpholine is a chemical compound with the molecular formula C11H13N2O4. It is a morpholine derivative that contains a 4-(2-methoxy-4-nitrophenyl) group. 4-(2-methoxy-4-nitrophenyl)morpholine is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It is also known for its potential biological activity, particularly as an inhibitor of acetylcholinesterase. Additionally, it has been studied for its potential use in the treatment of neurodegenerative diseases such as Alzheimer's. Overall, 4-(2-methoxy-4-nitrophenyl)morpholine is a versatile and important chemical with various industrial and medical applications.

InChI:InChI=1/C11H14N2O4/c1-16-11-8-9(13(14)15)2-3-10(11)12-4-6-17-7-5-12/h2-3,8H,4-7H2,1H3

Upstream product

• 110-91-8 morpholine 
• 1009-36-5 2-chloro-5-nitroanisole 
• 454-16-0 1-fluoro-2-methoxy-4-nitrobenzene 
• 77337-82-7 1-bromo-2-methoxy-4-nitrobenzene 
• 865-48-5 sodium t-butanolate 
• 709-09-1 3,4-dimethoxynitrobenzene 

Downstream Products

• 482308-06-5 3-methoxy-4-morpholin-4-yl-phenylamine 
• 1574538-36-5 3-(4-cyclopropylphenoxy)-1-(3-methoxy-4-morpholinophenyl)pyrrolidin-2-one 
• 1574538-37-6 3-(4-cyclopropylphenoxy)-1-(3-methoxy-4-morpholinophenyl)pyrrolidin-2-one 
• 1574538-35-4 (±)-3-(4-cyclopropylphenoxy)-1-(3-methoxy-4-morpholinophenyl)pyrrolidin-2-one 
• 1574541-74-4 (±)-3-bromo-1-(3-methoxy-4-morpholinophenyl)pyrrolidin-2-one 

Relevant articles and documents

A class of FLT3 kinase inhibitors, preparation and application thereof

The invention relates to a class of FLT3 kinase inhibitors, preparation and application thereof, wherein specifically the compound has a structure represented by a formula (I), and all groups and substituents are defined in the specification. The invention also discloses a preparation method of the compound, and application of the compound in inhibition of FLT3.

Imidazopyridazine IRAK4 inhibitor, and preparation method and application thereof

The invention belongs to the field of medicines, and especially relates to an imidazopyridazine compound or a pharmaceutically acceptable salt thereof, a preparation method thereof, and an applicationof a medicinal composition of the compound or the salt in the treatment of tumors, inflammations, immunity and other diseases. The imidazopyridazine compound is a novel protein kinase IRAK4 inhibitor, and can selectively inhibit IRAK4 and downstream signaling pathways thereof. The compound has the structural formula I.

IMIDAZOPYRAZINE SYK INHIBITORS

Certain imidazopyrazines and pharmaceutical compositions thereof are provided herein. Methods of treating patients suf-fering from certain diseases and disorders responsive to the inhibition of Syk activity, which comprises administering to such patients an amount of an imidazopyrazine compound effective to reduce signs or symptoms of the disease or dis-order are provided.